Evolent Health
EVH
262 hedge funds and large institutions have $3.66B invested in Evolent Health in 2024 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 76 increasing their positions, 92 reducing their positions, and 38 closing their positions.
75% more funds holding in top 10
Funds holding in top 10: 4 → 7 (+3)
55% more first-time investments, than exits
New positions opened: 59 | Existing positions closed: 38
48% more capital invested
Capital invested by funds: $2.48B → $3.66B (+$1.18B)
8% more funds holding
Funds holding: 243 → 262 (+19)
0.2% less ownership
Funds ownership: 111.57% → 111.37% (-0.2%)
10% less call options, than puts
Call options by funds: $75.4M | Put options by funds: $84.2M
17% less repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 92
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lazard Asset Management
New York
|
+$51.7M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$36.8M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$36.7M |
| 4 |
Boston Partners
Boston,
Massachusetts
|
+$32.8M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$25.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$51.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$46.2M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$30.8M |
| 4 |
Holocene Advisors
New York
|
-$26.6M |
| 5 |
O
OrbiMed
New York
|
-$24.2M |
EVH Hedge Fund Activity: Q3 2024 in Review
262 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q3 2024, worth a combined $3.66B — up 48% from $2.48B a quarter earlier.
Buyers outnumbered sellers: 59 funds opened new EVH positions and 38 closed out — a net gain of 21 holders — while 76 added to existing stakes and 92 trimmed.
The largest buyer was Lazard Asset Management, adding an estimated $51.7M. The largest seller was Rock Springs Capital Management, cutting an estimated $51.7M.
- 262 institutional investors held Evolent Health (EVH) as of Q3 2024, up from 243 in Q2 2024.
- Funds reported $3.66B of Evolent Health stock for Q3 2024, up 48% quarter-over-quarter.
- 59 funds opened new Evolent Health positions in Q3 2024 and 38 closed out, a net change of +21 holders.
- The largest Evolent Health buyer in Q3 2024 was Lazard Asset Management, an estimated $51.7M added.
- The largest Evolent Health seller in Q3 2024 was Rock Springs Capital Management, an estimated $51.7M sold.
Based on aggregated 13F filings for Q3 2024.